Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
for
Lupus Nephritis
Location: West Long Branch NJ, Willow Grove PA, Rockville MD,
Sponsor: Aurinia Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07611214
Recruiting
A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors
for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Orlando FL, Nashville TN,
Sponsor: NEOK Bio, Inc.
Sex: All
Age: 18+
Code: NCT07612189
Phase1, Recruiting
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
for
Hematologic Neoplasms
Location: New York NY, Piscataway NJ, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07572006
Phase1, Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: Mooresville NC, Tampa FL, Crystal River FL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318610
Phase3, Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
for
Advanced Cancer, Advanced Solid Tumors
Location: Orlando FL, Nashville TN, New Orleans LA, Denver CO
Get alerts for new trials in your area by subscribing now
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, Providence RI, The Bronx NY, Wilkes-Barre PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase2, Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
for
HIV Infections
Location: Boston MA, Philadelphia PA, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT06665646
Phase1, Recruiting
Hormonal, Metabolic, and Signaling Interactions in PAH
for
Idiopathic Pulmonary Arterial Hypertension,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 0 - 70+
Code: NCT01884051
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase3, Recruiting
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
for
HER2-Positive Solid Tumor
Location: Nashville TN
Sponsor: Yuhan Corporation
Sex: All
Age: 18+
Code: NCT05523947
Phase1, Phase2, Recruiting
PREcision MEDicine In Achalasia (PREMEDIA) - Cohort
for
Type III Achalasia,
Location: Boston MA, Charlotte NC, Gainesville FL, Cleveland OH,
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT07293689
Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Boston MA, Waterford CT, Manchester CT, Greenwich CT,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase3, Recruiting
NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE)
Location: Boston MA, Worcester MA, Manhasset NY, New York NY,
Sponsor: Magenta Medical Ltd.
Sex: All
Age: 18 - 70+
Code: NCT07001332
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Montreal, Norfolk VA, Newark DE, Fairfield OH,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07566156
Phase3, Recruiting
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
for
SCC - Squamous Cell Carcinoma, Radiotracer,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18+
Code: NCT07217028
Phase1, Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
for
Lupus Erythematosus, Systemic
Location: Newark NJ, Voorhees Township NJ, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07438496
Phase3, Recruiting
A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
for
Severe Aortic Stenosis, Valve-in-valve Procedures
Location: Boston MA, The Bronx NY, Baltimore MD, Clearwater FL,